Login

Nemaura Medical Inc. 4 SEC Filings

Filed On Filing
09 Jan 2024 Form 4: Ghadar-Ghadr Arash, Chief Operating Officer

Bought 100,000 shares ($14K)

01 Feb 2022 Form 4: Natha Salim, Director

Granted 8,000 Stock Option (right to buy)

01 Feb 2022 Form 4: Moore Thomas Peter, Director

Granted 8,000 Stock Option (right to buy)

01 Feb 2022 Form 4: Mclarney Justin James, Chief Financial Officer

Received 22,293 shares as a grant or award

01 Feb 2022 Form 4: Johnson Timothy Christopher, Director

Granted 8,000 Stock Option (right to buy)

01 Feb 2022 Form 4: Chowdhury Dewan Fazlul Hoque, Director

Granted 8,000 Stock Option (right to buy)

01 Feb 2022 Form 4: Timol Bashir, Director

Granted 8,000 Stock Option (right to buy)

07 Jun 2018 Form 4: Timol Bashir, Director

Acquired 27,082,000 shares (Other Transaction) · Converted 27,082 Series A Convertible Preferred Stock

07 Jun 2018 Form 4: Ismail Sufyan, 10% owner

Acquired 22,705,000 shares (Other Transaction) · Converted 22,705 Series A Convertible Preferred Stock

07 Jun 2018 Form 4: Chowdhury Dewan Fazlul Hoque, Director

Acquired 87,537,000 shares (Other Transaction) · Converted 87.537 Series A Convertible Preferred Stock

05 Jun 2018 Form 4: Timol Bashir, Director

Disposed of 27,082,000 shares (Other Transaction) · Acquired 27,082 Series A Convertible Preferred Stock (Other Transaction)

05 Jun 2018 Form 4: Ismail Sufyan, 10% owner

Disposed of 22,705,000 shares (Other Transaction) · Acquired 22,705 Series A Convertible Preferred Stock (Other Transaction)

05 Jun 2018 Form 4: Chowdhury Dewan Fazlul Hoque, Director

Disposed of 87,537,000 shares (Other Transaction) · Acquired 87,537 Series A Convertible Preferred Stock (Other Transaction)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support